Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded revision note: v3.4.2. Removed prior funding-status notice and revision note v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide funding/status notice indicating potential delays and that the NIH Clinical Center is open. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary toggle and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the earlier entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study details, eligibility criteria, or other core content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section listing Ohio and Pennsylvania study sites and updated the page revision to v3.3.3.SummaryDifference0.3%

- Check85 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.3.1 has been removed from the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.